Literature DB >> 19016041

Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.

Michael Pinkawa1, Bernd Gagel, Branka Asadpour, Marc D Piroth, Jens Klotz, Holger Borchers, Gerhard Jakse, Michael J Eble.   

Abstract

PURPOSE: To evaluate seed displacements after permanent prostate brachytherapy considering different prostate levels. PATIENTS AND METHODS: In 61 patients, postimplant CT scans were performed 1 day and 1 month after an implant with stranded seeds. Seed and prostate surface displacements were determined relative to pelvic bones. Four groups of seed locations were selected: seeds at the base (n = 305; B), at the apex (n = 305; A), close to the urethra (n = 306; U), and close to the rectal wall (n = 204; R). The length of two strands (always containing four seeds) per patient was measured in all CT scans and compared.
RESULTS: The largest inferior seed displacements were found at the base: mean 5.3 mm (B), 2.2 mm (A), 2.7 mm (U), 3.3 mm (R; p < 0.001). Posterior displacements predominated both at the base and the central region: mean 2.2 mm (B), 2.0 mm (U), 0.8 mm (A), -0.6 mm (R; p < 0.001). With a decreasing edema between day 1 and 30 (mean prostate volume of 51 cm(3) vs. 41 cm(3); p < 0.001), a mean caudal prostate base displacement of 3.9 mm was found, whereas the mean inward displacement ranged from 1.2 to 1.6 mm at the remaining borders (lateral, anterior, posterior, apical). The analysis of the strand lengths revealed an implant compression between day 1 and 30 (mean 1.7 mm; p < 0.001).
CONCLUSION: The largest prostate tissue and seed displacements were observed at the prostate base, associated with an implant compression. Predominantly inferior and posterior displacements implicate consequential smaller preplanning margins at the apex and the posterior prostate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016041     DOI: 10.1007/s00066-008-1886-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  8 in total

1.  Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.

Authors:  Georgina Fröhlich; Péter Agoston; József Lövey; András Somogyi; János Fodor; Csaba Polgár; Tibor Major
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

2.  Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters.

Authors:  Hans Schiefer; Friedrich von Toggenburg; Wolf Seelentag; Ludwig Plasswilm; Gerhard Ries; Cornelius Lenggenhager; Hans-Peter Schmid; Thomas Leippold; Ladislav Prikler; Bernd Krusche; Jakob Roth; Daniel Engeler
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

3.  Radiation protection of persons living close to patients with radioactive implants.

Authors:  Theodor W Kaulich; Michael Bamberg
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

4.  Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brachytherapy.

Authors:  Yinkun Wang; Nicola J Nasser; Jette Borg; Elantholi P Saibishkumar
Journal:  J Contemp Brachytherapy       Date:  2015-06-09

5.  Unexpected Seed Migration in Prostate Brachytherapy Implants Coincident with Change in Seed Stranding Product.

Authors:  Jim Rose; Derek Liu; Oleksandr Boychak; Ron Sloboda; Nadeem Pervez; Albert Murtha; Don Yee; John Amanie; Nawaid Usmani
Journal:  Cureus       Date:  2017-05-12

6.  Long-term tumor control after brachytherapy for base-of-prostate cancer.

Authors:  Jason M Samuelian; David A Swanson; Rajat J Kudchadker; Thomas J Pugh; Deborah A Kuban; Andrew K Lee; Seungtaek Choi; Quynh-Nhu Nguyen; Teresa L Bruno; Steven J Frank
Journal:  J Contemp Brachytherapy       Date:  2011-12-30

7.  After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer.

Authors:  Satoshi Nakamura; Naoya Murakami; Koji Inaba; Akihisa Wakita; Kazuma Kobayashi; Kana Takahashi; Hiroyuki Okamoto; Rei Umezawa; Madoka Morota; Minako Sumi; Hiroshi Igaki; Yoshinori Ito; Jun Itami
Journal:  BMC Cancer       Date:  2016-05-03       Impact factor: 4.430

8.  Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers.

Authors:  Claire Meynard; Andres Huertas; Charles Dariane; Sandra Toublanc; Quentin Dubourg; Saik Urien; Marc-Olivier Timsit; Arnaud Méjean; Nicolas Thiounn; Philippe Giraud
Journal:  Radiat Oncol       Date:  2019-12-31       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.